Thousands of scientific publications discuss evidence on the efficacy of non-cancer generic drugs being tested for cancer. However, trying to manually identify and extract such evidence is intractable at scale. We introduce a natural language processing pipeline to automate the identification of relevant studies and facilitate the extraction of therapeutic associations between generic drugs and cancers from PubMed abstracts. We annotate datasets of drug-cancer evidence and use them to train models to identify and characterize such evidence at scale. To make this evidence readily consumable, we incorporate the results of the models in a web application that allows users to browse documents and their extracted evidence. Users can provide feedback on the quality of the evidence extracted by our models. This feedback is used to improve our datasets and the corresponding models in a continuous integration system. We describe the natural language processing pipeline in our application and the steps required to deploy services based on the machine learning models.

Machine translation services are a very popular class of Artificial Intelligence (AI) services nowadays but public's trust in these services is not guaranteed since they have been shown to have issues like bias. In this work, we focus on the behavior of machine translators with respect to gender bias as well as their accuracy. We have created the first-of-its-kind virtual environment, called VEGA, where the user can interactively explore translation services and compare their trust ratings using different visuals.

Competitive analysis is a critical part of any business. Product managers, sellers, and marketers spend time and resources scouring through an immense amount of online and offline content, aiming to discover what their competitors are doing in the marketplace to understand what type of threat they pose to their business' financial well-being. Currently, this process is time and labor-intensive, slow and costly. This paper presents Clarity, a data-driven unsupervised system for assessment of products, which is currently in deployment in the large IT company, IBM. Clarity has been running for more than a year and is used by over 1,500 people to perform over 160 competitive analyses involving over 800 products. The system considers multiple factors from a collection of online content: numeric ratings by online users, sentiments of reviews for key product performance dimensions, content volume, and recency of content. The results and explanations of factors leading to the results are visualized in an interactive dashboard that allows users to track their product's performance as well as understand main contributing factors. Its efficacy has been tested in a series of cases across IBM's portfolio which spans software, hardware, and services.